The aim of this study is to investigate the effects of remote ischaemic preconditioning on the peripheral blood characteristics of healthy adults and to explore the possible mechanisms for improving ischaemia/reperfusion injury and its protective effects on the cardiovascular system.
Aged 18 to 45 years;
Be in good health;
Consent to participate in the clinical trial and sign the informed consent form.
Abnormal results in biochemical checks and physiological indicators.
Cardiovascular and cerebrovascular diseases: hypertension, coronary heart disease, congenital heart disease, cerebrovascular alterations, etc.
Endocrine diseases: diabetes, thyroid disorders, etc.
Hematologic diseases: anemia, paroxysmal hemoglobinuria, primary thrombocytosis, etc.